Becton Dickinson completes MicroProbe diagnostics purchase
This article was originally published in Clinica
Becton Dickinson has signed a binding agreement to purchase MicroProbe's name and its diagnostics business for $8.51 million. This figure could increase to $10.01 million depending on certain events. The deal was first announced in March (see Clinica No 644, p 13).